These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11560253)

  • 41. Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-β1-Smad4-PAI-1 axis.
    Chen L; Lu X; Zeng T; Chen Y; Chen Q; Wu W; Yan X; Cai H; Zhang Z; Shao Q; Qin W
    Oncol Rep; 2014 Feb; 31(2):885-93. PubMed ID: 24337404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
    Li SQ; Wang DM; Zhu S; Ma Z; Li RF; Xu ZS; Han HM
    Hum Exp Toxicol; 2015 Nov; 34(11):1053-72. PubMed ID: 25585999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased expression of epithelial cell adhesion molecule (EpCAM) in rat hepatic tumors induced by diethylnitrosamine.
    Kang JS
    Asian Pac J Cancer Prev; 2012; 13(8):3627-30. PubMed ID: 23098445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NTP technical report on the toxicology and carcinogenesis studies of beta-myrcene (CAS No. 123-35-3) in F344/N rats and B6C3F1 mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2010 Dec; (557):1-163. PubMed ID: 21415873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver.
    Kim Y; Sills RC; Houle CD
    Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis.
    Lee GH
    Toxicol Pathol; 2000; 28(2):215-25. PubMed ID: 10805139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of retinoid X receptor alpha is decreased in 3'-methyl-4-dimethylaminoazobenzene-induced hepatocellular carcinoma in rats.
    Ando N; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Tsurumi H; Tanaka T; Moriwaki H
    Oncol Rep; 2007 Oct; 18(4):879-84. PubMed ID: 17786350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma.
    Kira S; Nakanishi T; Suemori S; Kitamoto M; Watanabe Y; Kajiyama G
    Liver; 1997 Aug; 17(4):177-82. PubMed ID: 9298487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of EGFR-Stat3 signal pathway in carcinogenesis of experimental hepatoma in rats.
    Yu XT; Zhu SN; Xu ZD; Hu XQ; Zhu TF; Chen JQ; Lu SL
    J Cancer Res Clin Oncol; 2007 Mar; 133(3):145-52. PubMed ID: 17031671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
    Lapis K; Sarosi I; Bocsi J; Thorgeirsson UP
    Lab Invest; 1995 Jun; 72(6):748-59. PubMed ID: 7540236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Image cytometric comparison of proliferating cell nuclear antigen and MIB-1 staining in hepatocellular carcinoma and adjacent liver tissue.
    Wells SJ; DeRose PB; Cohen C
    Cytometry; 1996 Sep; 26(3):198-203. PubMed ID: 8889391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
    Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
    Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical stains of proliferating cell nuclear antigen, insulin-like growth factor 2 and clusterin help distinguish malignant from benign liver nodular lesions.
    Lai JP; Chen ZM; Lok T; Chan OT; Himmelfarb E; Zhai Q; Lin F; Wang HL
    J Clin Pathol; 2014 Jun; 67(6):464-9. PubMed ID: 24407433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simultaneous induction of liver cirrhosis and hepatocellular carcinomas in F-344 rats: establishment of a short hepatocarcinogenesis model.
    Zalatnai A; Lapis K
    Exp Toxicol Pathol; 1994 Aug; 46(3):215-22. PubMed ID: 8000242
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transplanted bone marrow stromal cells are not cellular origin of hepatocellular carcinomas in a mouse model of carcinogenesis.
    Zheng JF; Liang LJ
    World J Gastroenterol; 2008 May; 14(19):3015-20. PubMed ID: 18494052
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma.
    Qian C; Idoate M; Bilbao R; Sangro B; Bruña O; Vázquez J; Prieto J
    Hum Gene Ther; 1997 Feb; 8(3):349-58. PubMed ID: 9048202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Influence of spleen on cell cycle and expression of proliferating cell nuclear antigen of the liver during diethylnitrosamine-induced rat hepatocarcinogenesis].
    Wang G; Chen X; Qiu F; Tao D
    Zhonghua Wai Ke Za Zhi; 2002 Aug; 40(8):613-5. PubMed ID: 12417078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between expression of transforming growth factor-alpha and progression of hepatocellular foci to neoplasms.
    Kaufmann WK; Zhang Y; Kaufman DG
    Carcinogenesis; 1992 Aug; 13(8):1481-3. PubMed ID: 1499100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine.
    Horiguchi N; Takayama H; Toyoda M; Otsuka T; Fukusato T; Merlino G; Takagi H; Mori M
    Oncogene; 2002 Mar; 21(12):1791-9. PubMed ID: 11896611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
    Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
    Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.